Skip to content

KNSAKINIKSA PHARMACEUTICALS INTE

CUSIP G52694109 · common stock

4 tracked investors held KINIKSA PHARMACEUTICALS INTE (KNSA) at the end of Q3 2026, worth $236.7M in total. The largest holder was Julian Baker, with 1.0% of its portfolio.

Holders · Q3 2026
4
New holders
0
Value held
$236.7M
Quarter-end price (est.)
$74.61

Investors holding KNSA · Q3 2026

InvestorWeightSharesValueChange
Julian Baker
Baker Bros. Advisors LP
1.00%2,834,643$211.5MHOLD
Ken Fisher
Fisher Asset Management, LLC
0.01%323,808$24.2MREDUCE-18.7%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.03%9,258$690.7KREDUCE-65.6%
Joel Greenblatt
Gotham Asset Management, LLC
0.00%4,219$314.8KREDUCE-12.1%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026400$236.7M$74.61
Q2 2026400$208.8M$63.95
Q1 2026400$158.4M$48.15
Q4 2025400$129.1M$41.25